With rapid urbanization and economic development,obesity has emerged as a major public health concern in China.According to the latest Global Burden of Diseases study,there were 402 million overweight and obese Chines...With rapid urbanization and economic development,obesity has emerged as a major public health concern in China.According to the latest Global Burden of Diseases study,there were 402 million overweight and obese Chinese adults in 2021 and this number is projected to further increase to 627 million by 2050[1].Obesity is closely associated with an elevated risk of type 2 diabetes,cardiovascular and cerebrovascular diseases,depression,and certain cancers[2,3].In addition to being a risk factor,excess adiposity can directly damage end-organs and affect the ability to conduct daily activities[4].In this comment,we aim to provide an overview of the epidemiology of obesity among Chinese adults based on the China Chronic Disease and Risk Factor Surveillance(CCDRFS)and summarize the related determinants and health policies against obesity.展开更多
The global average life expectancy is projected to rise to 80 years by 2040[1].Since cancer is closely linked to aging,its prevalence is expected to grow as the population ages.Advancements in cancer diagnosis and tre...The global average life expectancy is projected to rise to 80 years by 2040[1].Since cancer is closely linked to aging,its prevalence is expected to grow as the population ages.Advancements in cancer diagnosis and treatment have led to an increasing number of cancer survivors.In a 2021 consensus statement,the International Society for Geriatric Oncology updated its top priorities for improving care for older cancer patients[2,3].According to the Global Burden of Disease(GBD)study,there were over four million deaths from gastrointestinal(GI)cancer in 2021[4].The aging population,advancements in cancer management,and shifting risk factors are undoubtedly influencing the prevalence of GI cancers in older adults[5].While aging has increasingly captured the attention of policymakers and stakeholders,epidemiological data on GI cancers in older adults remains limited.Older patients are also underrepresented in GI-specific clinical trials.This study aimed to estimate the global burden of GI cancers in older adults using the most recent GBD 2021[6].展开更多
基金funded by the Noncommunicable Chronic Diseases-National Science and Technology Major Project(2024ZD0531504)the Young Scholar Science Foundation of the China Center for Disease Control and Prevention(2023A202).
文摘With rapid urbanization and economic development,obesity has emerged as a major public health concern in China.According to the latest Global Burden of Diseases study,there were 402 million overweight and obese Chinese adults in 2021 and this number is projected to further increase to 627 million by 2050[1].Obesity is closely associated with an elevated risk of type 2 diabetes,cardiovascular and cerebrovascular diseases,depression,and certain cancers[2,3].In addition to being a risk factor,excess adiposity can directly damage end-organs and affect the ability to conduct daily activities[4].In this comment,we aim to provide an overview of the epidemiology of obesity among Chinese adults based on the China Chronic Disease and Risk Factor Surveillance(CCDRFS)and summarize the related determinants and health policies against obesity.
文摘The global average life expectancy is projected to rise to 80 years by 2040[1].Since cancer is closely linked to aging,its prevalence is expected to grow as the population ages.Advancements in cancer diagnosis and treatment have led to an increasing number of cancer survivors.In a 2021 consensus statement,the International Society for Geriatric Oncology updated its top priorities for improving care for older cancer patients[2,3].According to the Global Burden of Disease(GBD)study,there were over four million deaths from gastrointestinal(GI)cancer in 2021[4].The aging population,advancements in cancer management,and shifting risk factors are undoubtedly influencing the prevalence of GI cancers in older adults[5].While aging has increasingly captured the attention of policymakers and stakeholders,epidemiological data on GI cancers in older adults remains limited.Older patients are also underrepresented in GI-specific clinical trials.This study aimed to estimate the global burden of GI cancers in older adults using the most recent GBD 2021[6].
